Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Diabetes in Developing Countries
Published in: International Journal of Diabetes in Developing Countries 1/2018

01-01-2018 | Original Article

Emergence of multi drug resistance strains causing diabetic foot infection in Salem, Tamil Nadu, India

Authors: Pugazhendhi Sugandhi, Dorairaj Arvind Prasanth

Published in: International Journal of Diabetes in Developing Countries | Issue 1/2018

Login to get access

Abstract

This study was to assess the emergence of mecA and bla CTX-M in multidrug resistant MRSA/MRSE and ESBL strains in diabetic foot infections. A total of 160 pus samples were collected from the diabetic foot care hospitals, Salem, Tamil Nadu, India. The samples were processed for microbiological investigations and further evaluating the resistant strains. The bacterial strain Staphylococcus aureus was the predominant organisms isolated from the sample. Cefoxitin, Oxacillin and Vancomycin were found to be the most effective antimicrobial agents for therapy of gram positive organisms while Meropenem, Piperacillin, Cefoperazone/Sulbactam, Piperacillin/ Tazobactam and Amikacin were found to be the most effective antimicrobial agents for the gram negative organisms. In this study, four isolates of Methicillin resistant Staphylococcus aureus (MRSA) strains, one isolate of Methicillin resistant Staphylococcus epidermidis (MRSE) and five isolates of Pseudomonas aeruginosa were found to be extended spectrum of β - lactamase (ESBL) producers by phenotypic method. These strains subjected to genotypic confirmation confirmed the presence of resistant genes namely bla CTX-M in ESBL and SCC mecA in Staphylococcus spp. The 16S rRNA partial gene sequencing and phylogenetic analysis of the multi drug resistant organisms Pseudomonas aeruginosa (APS01) and Staphylococcus epidermidis (APS02) was confirmed the resistant pattern in these strains. The resistant organism was eradicated only by the effective management of this infection; knowledge on the causative agent causing cruel diabetic foot infections will be very useful in selecting the appropriate therapy.
Literature
1.
Abd Hamead Hefni A, Metwally R, Ibrahim Khaled M, Attia Mahmoud M, Moawad Ayman F, Eramah Mohamed M, et al. Bacteriological study of diabetic foot infection in Egypt. J Arab Soc Med Res. 2013;8:26–32.
2.
Edward Boyko J, Jessie Ahroni H, Stensel V, Ruby Forsberg C, Denise Davignon R, Douglas Smith G. A prospective study of risk factors for diabetic foot ulcer. Diabetes Care. 1999;22(7):1036–42.CrossRef
3.
Mendes JJ, Marques Costa A, Vilela C, Neves J, Candeias N, Cavaco Silva P, et al. Clinical and bacteriological survey of diabetic foot infections in Lisbon. Diab Res Clin Pract. 2012;95:153–61.CrossRef
4.
5.
Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care. 2006;29:1727–32.CrossRefPubMed
6.
Mathur T, Singhal S, Khan S, Upadhyay DJ, Fatma T, Rattan A. Detection of biofilm formation among the clinical isolates of Staphylococci: an evaluation of three different screening methods. Indian J Med Microbiol. 2006;24:25–9.CrossRefPubMed
7.
Zubair M, Malik A, Ahmad J. Study of plasmid mediated extended spectrum beta lactamase producing strains of Enterobacteriaceae, isolated from foot infections in north Indian tertiary care hospital. Diabetes Technol Therap. 2012;12(4):315–24.CrossRef
8.
John Holt G. Bergey’s Manual of Determinative Bacteriology. 9th Edition. United States of America; 2000.
9.
Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 11th Edition. 2012; 32: 1.
10.
Sambrook, Russell. Molecular cloning - a laboratory manual. 3rd ed. Newyork: Cold spring harbor laboratory press; 2001.
11.
Leela Rani K, Madhumathi, Belwadi S, Ramana BV. Bacteriological profile of diabetic foot ulcer. Int J Pharma Res Bio. 2013;2(2):36–45.
12.
Dhanasekaran G, Sastry G, Viswanathan M. Microbial pattern of soft tissue infections in diabetic patients in South India. Asian J Diabet. 2003;5:8–10.
13.
Tiwari S, Pratyush DD, Dwivedi A, Gupta SK, et al. Microbiological and clinical characteristics of diabetic foot infections in northern India. J Infect Dev Ctries. 2012;6(4):329–32.PubMed
14.
Abdulrazak A, Bitar ZI, Al-Shamali AA, Mobasher LA. Bacteriological study of diabetic foot infections. J Diab Complicat. 2005;19:138–41.CrossRef
15.
Sharma VK, Khakda PB, Joshi A, Sharma R. The common pathogens which were isolated from diabetic foot infections in Bir hospital. Kathmandu Univ Med J. 2006;4(3):295–301.
16.
Rajalakshmi V, Amsaveni V. Antibiotic susceptibility of bacterial pathogens isolated from diabetic patients. Int J Microbio Res. 2012;3(1):30–2.
17.
Lipsky BA. Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection. Clin Microbiol Infect. 2007;13:351–3.CrossRefPubMed
18.
Citron DM, Goldstein EJC, Merriam CV, Lipsky BA, Abraham MA. Bacteriology of the moderate to severe diabetic foot infections and the in vitro activity of the antimicrobial agents. J Clin Microbiol. 2007;45(9):2819–28.CrossRefPubMedPubMedCentral
19.
Zubair M, Malik A, Ahmadb J. The impact of creatinine clearance on the outcome of diabetic foot ulcers in north Indian tertiary care hospital. Diabetes Met Syn: Clin Res Rev. 2011;5:120–5.CrossRef
20.
Zhang K, McClure JA, Elsayed S, Conly JM. Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class a mec and type 4 ccr gene complexes in a canadian epidemic strain of Methicillin resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2009;53(2):531–40.CrossRefPubMed
21.
Miragaia M, Couto I, Pereira SF, Kristinsson KG, Westh H, Jarlov JO, Carrico J, Almeida J, Santos Sanches I, De Lencastre H. Molecular characterization of Methicillin resistant Staphylococcus epidermidis clones: evidence of geographic dissemination. J Clin Microbiol. 2002;40:430–8.CrossRefPubMedPubMedCentral
22.
Duarte Oliveira C, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in Methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2002;46(7):2155–61.CrossRefPubMed
23.
Pitout JDD, Nordmann P, Laupland KB, Poirel L. Emergence of enterobacteriaceae producing extended-spectrum beta lactamases (ESBLs) in the community. J Antimicrobiol Chemother. 2005;56:52–9.CrossRef
24.
Nashwan al Naiemi, Birgitta Duim, Aldert Bart. A CTX-M extended spectrum beta lactamases in Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J Med Microbiol. 55: 1607–1608.
25.
Polotto M, Casella T, de Lucca Oliveira MG, Rubio FG, Mauricio L, et al. Detection of P.aeruginosa harboring bla CTX-M-2 , bla GES-1 and bla GES-5 , bla IMP-1 and bla SPM-1 causing infections in brazilian tertiary care hospital. BMC Infect Dis. 2012;12:176.CrossRefPubMedPubMedCentral
26.
Farshadzadeh Z, Khosravi AD, Alavi SM, Parhizgari N, Hoveizavi H. Spread of extended-spectrum β-lactamase genes of bla OXA-10 , bla PER-1 and bla CTX-M in Pseudomonas aeruginosa strains isolated from burn patients. Burns. 2014;40(8):1575–80.CrossRefPubMed
27.
Relman DA, Schmidt TM, Mac Dermott RP, Falkow S. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med. 1992;327:293–301.CrossRefPubMed
28.
Santos Sanches I, Mato R, de Lencastre H, Tomasz A, Nunes S, Alves CR, et al. Patterns of multidrug resistance among Methicillin-resistant hospital isolates of coagulase positive and coagulase negative Staphylococci collected in the international multicenter study resist in 1997 and 1998. Microb Drug Res. 2000;6:199–211.CrossRef
29.
30.
Kandemir O, Akbay Sahin E, Millan A, Gen R. Risk factor for infection of the diabetic foot with multi-antibiotic resistant microorganisms. J Inf Secur. 2007;54:439–45.
Metadata
Title
Emergence of multi drug resistance strains causing diabetic foot infection in Salem, Tamil Nadu, India
Authors
Pugazhendhi Sugandhi
Dorairaj Arvind Prasanth
Publication date
01-01-2018
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 1/2018
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-017-0555-4

Other articles of this Issue 1/2018

International Journal of Diabetes in Developing Countries 1/2018 Go to the issue

Original Article

Automatic detection of retinal hemorrhages by exploiting image processing techniques for screening retinal diseases in diabetic patients

Original Article

Early diagnosis of gestational diabetes mellitus during the first trimester of pregnancy based on the one-step approach of the International Association of Diabetes and Pregnancy Study Groups

Original Article

Serum oxidized LDL and the factors associated with LDL oxidation in black South African type 2 diabetes mellitus patients

Original Article

Factors contributing to effective referral systems for patients with non-communicable disease: evidence-based practice

Original Article

Prevention of type 2 diabetes mellitus by changes in diet among subjects with abnormal glucose metabolism: a randomized clinical trial

Original Article

Association of risk factors with a major re-amputation in Malaysian diabetic patients: a retrospective cohort analysis of patient registry
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits